Vetnews | Junie 2025 38 « BACK TO CONTENTS Superficial pyoderma in dogs remains one of the most common dermatological presentations in general practice. But as with many routine conditions, it’s easy to fall into the trap of treating it as a straightforward bacterial infection. In reality, superficial pyoderma is often a multifactorial syndrome, driven not only by infection but also by underlying inflammation, barrier dysfunction, and commensal overgrowth. Inflammation drives infection Superficial pyoderma is technically defined as a bacterial infection confined to the epidermis and hair follicles. Staphylococcus pseudintermedius (a commensal skin bacteria) is usually the culprit. We now understand that the overgrowth of commensal bacteria like Staph doesn’t happen in a vacuum. In many cases, cutaneous inflammation precedes infection. Allergic dermatitis (atopic or cutaneous adverse food reaction), ectoparasites, or frictional trauma (like skin fold dermatitis) can all disrupt the skin barrier. Once the barrier is compromised, the resident microbiota can shift from commensal to opportunistic. Opportunistic infections of the skin contribute to inflammation and so the vicious cycle of inflammation-infection sets in. The other common skin commensal organism, Malassezia, is often a great contributor to this cycle - not merely an innocent bystander. Malassezia: The Unsung Aggravator While pyoderma implies a focus on bacteria, Malassezia plays a pivotal role in many of these cases. Failure to address the concurrent Malassezia overgrowth will result in failure of clinical resolution or relapse as soon as antimicrobial therapy is stopped. This commensal yeast thrives in lipid-rich, inflamed environments. It contributes to skin barrier dysfunction by producing lipases and proteases that can break down the bonds between skin cells in the outer dead layer of the skin (the stratum corneum), which acts as the skin’s main physical barrier. In dogs with allergic skin disease, we often see a MalasseziaStaphylococcal loop: inflammation promotes yeast overgrowth, which fuels more inflammation, which in turn supports bacterial overgrowth. Recognizing and breaking this cycle is key to effective management. Ignoring Malassezia in cases of recurrent or treatment-resistant pyoderma may set you and your client up for frustration. Cytology: Your Clinical Compass A simple, fast, inexpensive tool that we often underutilize is inhouse cytology. Not only can it confirm the presence of bacteria or yeast, but it also provides information about the relative load and the degree of inflammation. It will also differentiate primary pathogens such as Pseudomonas or Klebsiella from opportunistic overgrowth of Staphylococcus. This distinction matters because not all overgrowth is infection. In some cases, what appears to be pyoderma may actually be overgrowth without true invasion. These cases may respond to topical therapy alone or require a different primary treatment target (i.e. allergy control). However, high neutrophil counts with intracellular cocci indicating phagocytosis confirm infection and justify systemic antimicrobial use. Cytology supports responsible antimicrobial stewardship, helping us avoid unnecessary antibiotics while also ensuring we treat genuine infections effectively. Techniques for sample collection include direct impression (the author’s preferred collection method), acetate tape (can yield too many dead skin cells of dry lesions which makes the microscopic field quite busy and difficult to interpret), swab collection and rolling onto slide (good for exudative purulent discharges or interdigital areas). Superficial Pyoderma in Dogs: More Than Just a Bacterial Problem By Monica Burger, BSc BVSc (UP) Image showing Staphylococcus as overgrowth without invasion (note the lack of neutrophils and the lack of Malassezia). This patient responded well to topical therapy alone.
RkJQdWJsaXNoZXIy OTc5MDU=